CHARLES SHOULTZ: Open Payments
NPI 1780680496 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,091 in 50 payments from 9 companies in 2025. Trend: 2023 $9,494 · 2024 $8,298 · 2025 $5,091
Food & beverage: $3,030Travel & lodging: $2,061
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 10 | $3,300 |
| Medtronic, Inc. | 13 | $1,025 |
| Novartis Pharmaceuticals Corporation | 19 | $226 |
| Boston Scientific Corporation | 2 | $179 |
| Teleflex LLC | 1 | $152 |
| Cleerly, Inc. | 2 | $140 |
| Bard Peripheral Vascular, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: Indigo System, SYMPLICITY G3, LEQVIO, ABRE, Penumbra System, ONYX FRONTIER, COREVALVE EVOLUT R, General - Vascular Access.
Industry payments across TX — which companies pay providers there.
